GIP/GLP-1 receptor agonist
Generic name: tirzepatide
US Retail Price
$1,000–$1,100/month
With copay card: As low as $25/month (commercially insured)
Manufacturer
Eli Lilly
Used For
Type 2 diabetes management; significant weight loss as a side effect
Mounjaro (tirzepatide) is FDA-approved for type 2 diabetes and is the same molecule as Zepbound (approved for weight loss). It is the most effective GLP-1 class drug for A1C reduction and weight loss. Eli Lilly offers a savings card for commercially insured patients and sells single-dose vials at lower cost through LillyDirect.
Eli Lilly's Mounjaro savings card reduces cost to as low as $25/month for commercially insured patients. Not available for Medicare/Medicaid patients. Enroll at the Mounjaro savings page.
Get Lilly Savings CardEli Lilly sells tirzepatide in single-dose vials directly to self-pay patients through LillyDirect at significantly reduced prices. Requires a prescription. This is the same molecule as Mounjaro/Zepbound.
Explore LillyDirect VialsMounjaro is available from verified international pharmacies in Canada and other countries at lower prices than US retail. Use PharmacyChecker to compare verified international sources.
Compare International PricesEli Lilly's Lilly Cares Foundation patient assistance program may provide free Mounjaro for qualifying low-income patients who meet income and insurance eligibility criteria.
Search NeedyMedsGoodRx coupons can reduce Mounjaro costs at US pharmacies. Savings are modest compared to the savings card but useful for patients who don't qualify for the manufacturer program.
Check GoodRx PriceLooking for another medication?
The Med Map covers all 8 categories of savings options for hundreds of drugs.
Back to The Med Map